Onderneming Acurx Pharmaceuticals, Inc.
Aandelen
ACXP
US00510M1045
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,97 USD | -5,29% | -10,45% | -48,56% |
Vakgebied
Aantal werknemers: 4
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Shawah
FOU | Founder | 57 | 01-07-17 |
David Luci
FOU | Founder | 57 | 01-07-17 |
Chief Tech/Sci/R&D Officer | - | - | |
Lisa Wilson
IRC | Investor Relations Contact | - | - |
Mintz Levin
LAW | General Counsel | - | - |
Larry Mortin
PRN | Corporate Officer/Principal | - | - |
Xiang Yu
PRN | Corporate Officer/Principal | - | - |
Les Johnson
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert de Luccia
FOU | Founder | 78 | 01-07-17 |
Joseph Scodari
BRD | Director/Board Member | 71 | 24-06-21 |
Thomas Harrison
BRD | Director/Board Member | 76 | 24-06-21 |
David Luci
FOU | Founder | 57 | 01-07-17 |
Carl Sailer
BRD | Director/Board Member | 54 | 23-10-18 |
Jack Dean
BRD | Director/Board Member | 82 | 24-06-21 |
James J. Donohue
BRD | Director/Board Member | 54 | 24-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 823 102 | 13 418 479 ( 84,80 %) | 0 | 84,80 % |
Bedrijfsgegevens
Acurx Pharmaceuticals, Inc.
259 Liberty Avenue Staten Island
10305, New York
+917 533 1469
http://www.acurxpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-48,56% | 32,91 mln. | |
+21,74% | 46,81 mld. | |
-0,97% | 41,37 mld. | |
+47,07% | 41,29 mld. | |
-3,52% | 28,87 mld. | |
+11,12% | 26,06 mld. | |
-19,37% | 19,13 mld. | |
+31,18% | 12,39 mld. | |
-0,04% | 12,08 mld. | |
+0,39% | 11,96 mld. |
- Beurs
- Aandelen
- Koers ACXP
- Onderneming Acurx Pharmaceuticals, Inc.